Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) was the target of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 3,380,000 shares, a decline of 14.4% from the June 15th total of 3,950,000 shares. Approximately 4.2% of the shares of the company […]
Shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) have received an average rating of “Hold” from the five brokerages that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month target price […]
Palisade Capital Management LLC NJ cut its position in Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 742,289 shares of the company’s stock after selling 27,602 shares during the quarter. Palisade Capital Management LLC […]
Shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) have been assigned a consensus rating of “Hold” from the eight analysts that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year […]
Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) Director Mark S. Ordan sold 33,000 shares of Pediatrix Medical Group stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $13.26, for a total transaction of $437,580.00. Following the completion of the transaction, the director now directly […]